News Alerts

Principal Investigator of Microbicide Trials Network Informs Colleagues of Co-Enrollment in HPTN 035 and CAPRISA 004 Trials

06 May 2008 - MTN leadership sent a letter to colleagues today on the co-enrollment of approximately 96 HPTN 035 participants into the CAPRISA 004 study. Investigators involved in these trials are working together to determine how this happened, how it may affect study participants and trial outcomes, and what lessons can be learned and applied to future trials. Read more...

Alliance for Microbicide Development Launches New Website

05 May 2008 - The Alliance for Microbicide Development launches an improved website today, www.microbicide.org. Read more...

International Partnership for Microbicides (IPM) Receives License from Merck & Co., Inc. for Antiretroviral Compound for Use as a Microbicide

11 March 2008 - Merck & Co., Inc. has agreed to provide a royalty-free license to the non-profit International Partnership for Microbicides (IPM) to develop a novel antiretroviral compound, called L'644, for use as a potential vaginal microbicide. Read more...

National Institutes of Health's Integrated Preclinical/ Clinical Program for HIV Topical Microbicides Funding Opportunity Announcement

11 March 2008 - The National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Mental Health (NIMH) invite applications from single institutions and consortia of institutions to participate in this Funding Opportunity Announcement (FOA) for the Integrated Preclinical/Clinical Program for HIV Topical Microbicides (IPCP-HTM). Read more...

FDA Warns Companies Importing and Marketing Drugs Over the Internet that Fraudulently Claim to Prevent and Treat STDs

11 March 2008 - The U.S. Food and Drug Administration issued Warning Letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded drugs over the Internet to U.S. consumers for the prevention and treatment of sexually transmitted diseases (STDs). Read more...